Cargando…

Calculating an estimate of tissue integrated activity in (18)F-FDG PET imaging using one SUV value

BACKGROUND: A kinetic model analysis was recently proposed to estimate the 18F-fluorodeoxyglucose ((18)F-FDG) integrated activity in an arbitrary tissue that uses tracer uptake and release rate constants. The aim of the current theoretical paper was to estimate (18)F-FDG integrated activity using on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laffon, Eric, Bardiès, Manuel, Barbet, Jacques, Marthan, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772744/ https://www.ncbi.nlm.nih.gov/pubmed/23561423 http://dx.doi.org/10.1186/2191-219X-3-26

Ejemplares similares

Utility of SUV(max) on (18) F-FDG PET in detecting cervical nodal metastases
por: Lim, Rebecca S. M., et al.
Publicado: (2016)

Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor
por: Zwezerijnen, Gerben J. C., et al.
Publicado: (2022)

Comparison of three-parameter kinetic model analysis to standard Patlak’s analysis in (18)F-FDG PET imaging of lung cancer patients
por: Laffon, E., et al.
Publicado: (2018)

Correlation of (18)F-FDG/PET SUV(max), SUV(mean), MTV, and TLG with HIF-1α in Patients with Colorectal Cancer
por: Kaymak, Zümrüt Arda, et al.
Publicado: (2021)

Correction to: Comparison of three-parameter kinetic model analysis to standard Patlak’s analysis in (18)F-FDG PET imaging of lung cancer patients
por: Laffon, E., et al.
Publicado: (2019)

Prognostic value of nodal SUV(max) of (18)F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Lee, So Jung, et al.
Publicado: (2017)

Relation between nodule size and (18)F-FDG-PET SUV for malignant and benign pulmonary nodules.
por: Khalaf, Majid, et al.
Publicado: (2008)

Prognostic Prediction of BRCA Mutations by (18)F-FDG PET/CT SUV(max) in Breast Cancer
por: Özdemir, Semra, et al.
Publicado: (2021)

18F-FDG PET/CT scan standardised uptake value (SUV) score for diagnosis, staging and monitoring malignancy in spinal melanotic schwannoma
por: Haleem, Shahnawaz, et al.
Publicado: (2022)

18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC)
por: Bernstine, Hanna, et al.
Publicado: (2018)

Simultaneous [(18)F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer
por: Brandmaier, P., et al.
Publicado: (2015)

Diagnostic efficiency of whole-body (18)F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer
por: Steiner, Aida, et al.
Publicado: (2021)

SUV(fdg): A standard-uptake-value (SUV) body habitus normalizer specific to fluorodeoxyglucose (FDG) in humans
por: Beattie, Bradley J., et al.
Publicado: (2022)

Association Between (18)F-FDG PET/CT-Based SUV Index and Malignant Status of Persistent Ground-Glass Nodules
por: Niu, Rong, et al.
Publicado: (2021)

Normal SUV Values Measured from NaF18- PET/CT Bone Scan Studies
por: Win, Aung Zaw, et al.
Publicado: (2014)

Comparison of SUV(max) Values Obtained from F-18 FDG PET/CT and Cell-free DNA Levels Measured from Plasma in Oncology Patients
por: Çelik, Fatmanur, et al.
Publicado: (2019)

The value on SUV-derived parameters assessed on (18)F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer
por: Liao, Xuhe, et al.
Publicado: (2023)

For avid glucose tumors, the SUV peak is the most reliable parameter for [(18)F]FDG-PET/CT quantification, regardless of acquisition time
por: Sher, Avigaëlle, et al.
Publicado: (2016)

FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements
por: Osman, Medhat M., et al.
Publicado: (2011)

Exploration of the threshold SUV for diagnosis of malignancy using (18)F-FBPA PET/CT
por: Isohashi, Kayako, et al.
Publicado: (2022)

Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer
por: Garcia-Vicente, Ana María, et al.
Publicado: (2017)

The reproducibility of MTV and TLG of soft tissue tumors calculated by FDG-PET: Comparison between the lower limit by the fixed value SUV 2.5 and that value by 30% of SUVmax
por: Iwasa, Hitomi, et al.
Publicado: (2023)

The correlation of expression of VEGF and EGFR with SUV of (18)FDG-PET-CT in non-small cell lung cancer
por: Liu, Xiguang, et al.
Publicado: (2014)

Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUV(max) in [(18)F]fluoride and [(18)F]FDG PET?
por: Azad, Gurdip K., et al.
Publicado: (2018)

Diagnostic Value of (18)F-FDG-PET/CT in Patients with FUO
por: Georga, Stamata, et al.
Publicado: (2020)

dAcquisition setting optimization and quantitative imaging for (124)I studies with the Inveon microPET-CT system
por: Anizan, Nadège, et al.
Publicado: (2012)

FDG-PET staging and importance of lymph node SUV in head and neck cancer
por: Kubicek, Gregory J, et al.
Publicado: (2010)

Added value of regional (18)F-FDG PET/MRI-assisted whole-body (18)F-FDG PET/CT in malignant ascites with unknown primary origin
por: Fu, Yiru, et al.
Publicado: (2023)

Diagnostic value of (18)F-FDG-PET/CT in benign lung diseases
por: Ergonul, Ayse Gul, et al.
Publicado: (2018)

Differential diagnostic value of (18)F-FDG PET/CT in osteolytic lesions
por: Li, Xiaomeng, et al.
Publicado: (2020)

PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT
por: Morita, Takahiro, et al.
Publicado: (2017)

Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2019)

18 F-FDG-PET/MRI in patients with Graves’ orbitopathy.
por: Weber, Manuel, et al.
Publicado: (2021)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
por: Allahqoli, Leila, et al.
Publicado: (2023)

Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing (18)F-FDG PET/CT SUV quantification
por: Cistaro, Angelina, et al.
Publicado: (2013)

(18)F-FDG PET/CT SUV(max) and serum CEA levels as predictors for EGFR mutation state in Chinese patients with non-small cell lung cancer
por: Gao, Xi-Can, et al.
Publicado: (2020)

Estimation of optimal number of gates in dual gated (18)F-FDG cardiac PET
por: Klén, R., et al.
Publicado: (2020)

Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses
por: Launay, Nathalie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vn9k5hrmkgpej2fqqm1o2e83cs